Insider Trading Disclosure
Neochem Bio: MD Swapnil Makati bought 7,200 shares
Neochem Bio Solutions Ltd disclosed under Reg 7(2) that Managing Director Swapnil R. Makati purchased 7,200 equity shares (Form C); intimation dated 2026-09-10.

Investor Presentation
Q4 FY26
Investor Presentation
Q1 FY26
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
4
Neutral
7
Bullish
3
Bearish
5
Neutral
11
Bullish
30
Bearish
1
Neutral
4
Bullish
27
Industrial Products
Other Industrial Products
184 Cr
Moderate Risk
23.9
35.5
0.2
2.6
121.00
63.00
Sales CAGR
Profit CAGR
ROE
Bearish
4
Neutral
7
Bullish
3
Bearish
4
Neutral
7
Bullish
3
Bearish
1
Neutral
4
Bullish
27
Bearish
1
Neutral
4
Bullish
27
Bearish
1
Neutral
4
Bullish
27
ROCE
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Neochem Bio Solutions Ltd (NEOCHEM) is currently trading at 103.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Neochem Bio Solutions Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Neochem Bio Solutions Ltd has traded between a low of ₹63.00 and a high of ₹121.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Neochem Bio Solutions Ltd has a market capitalization of approximately 183.88. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Neochem Bio Solutions Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 23.92 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 183.88 Cr, Neochem Bio Solutions Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Neochem Bio Solutions Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Neochem Bio Solutions Ltd is 23.92. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.